11.07.2015 Views

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCAppendix 8: Internati<strong>on</strong>al St<strong>and</strong>ards for <strong>Tuberculosis</strong> CareIn 2006 <strong>the</strong> “Internati<strong>on</strong>al St<strong>and</strong>ards for <strong>Tuberculosis</strong> Care” were published to describe a widely acceptedlevel <strong>of</strong> care that all practiti<strong>on</strong>ers, public <strong>and</strong> private should seek to achieve <strong>in</strong> manag<strong>in</strong>g patients who haveor are suspected <strong>of</strong> hav<strong>in</strong>g tuberculosis. The st<strong>and</strong>ards are outl<strong>in</strong>ed below. The full document is available atwww.who.<strong>in</strong>t/tb/publicati<strong>on</strong>s/2006/istc_report.pdf.St<strong>and</strong>ards for DiagnosisSt<strong>and</strong>ard 1. All pers<strong>on</strong>s with o<strong>the</strong>rwise unexpla<strong>in</strong>ed productive cough last<strong>in</strong>g two to three weeks or moreshould be evaluated for tuberculosis.St<strong>and</strong>ard 2. All patients (adults, adolescents, <strong>and</strong> children who are capable <strong>of</strong> produc<strong>in</strong>g sputum)suspected <strong>of</strong> hav<strong>in</strong>g pulm<strong>on</strong>ary tuberculosis should have at least two <strong>and</strong> preferably three, sputumspecimens obta<strong>in</strong>ed for microscopic exam<strong>in</strong>ati<strong>on</strong>. When possible, at least <strong>on</strong>e early morn<strong>in</strong>g specimenshould be obta<strong>in</strong>ed.St<strong>and</strong>ard 3. For all patients (adults, adolescents, <strong>and</strong> children) suspected <strong>of</strong> hav<strong>in</strong>g extrapulm<strong>on</strong>arytuberculosis, appropriate specimens from <strong>the</strong> suspected sites <strong>of</strong> <strong>in</strong>volvement should be obta<strong>in</strong>ed formicroscopy <strong>and</strong>, where facilities <strong>and</strong> resources are available, for culture <strong>and</strong> histopathological exam<strong>in</strong>ati<strong>on</strong>.St<strong>and</strong>ard 4. All pers<strong>on</strong>s with chest radiographic f<strong>in</strong>d<strong>in</strong>gs suggestive <strong>of</strong> tuberculosis should have sputumspecimens submitted for microbiological exam<strong>in</strong>ati<strong>on</strong>.St<strong>and</strong>ard 5. The diagnosis <strong>of</strong> sputum smear-negative pulm<strong>on</strong>ary tuberculosis should be based <strong>on</strong> <strong>the</strong>follow<strong>in</strong>g criteria: at least three negative sputum smears (<strong>in</strong>clud<strong>in</strong>g at least <strong>on</strong>e early morn<strong>in</strong>g specimen),chest radiography f<strong>in</strong>d<strong>in</strong>gs c<strong>on</strong>sistent with tuberculosis <strong>and</strong> lack <strong>of</strong> resp<strong>on</strong>se to a trial <strong>of</strong> broad spectrumantimicrobial agents. (Note: Because <strong>the</strong> fluoroqu<strong>in</strong>ol<strong>on</strong>es are active aga<strong>in</strong>st M. tuberculosis complex <strong>and</strong>thus may cause transient improvement <strong>in</strong> pers<strong>on</strong>s with tuberculosis, <strong>the</strong>y should be avoided.) For suchpatients, if facilities for culture are available, sputum cultures should be obta<strong>in</strong>ed. In pers<strong>on</strong>s with known orsuspected HIV <strong>in</strong>fecti<strong>on</strong>, <strong>the</strong> diagnostic evaluati<strong>on</strong> should be expedited.St<strong>and</strong>ards for TreatmentSt<strong>and</strong>ard 6. The diagnosis <strong>of</strong> <strong>in</strong>trathoracic (i.e. pulm<strong>on</strong>ary, pleural, <strong>and</strong> mediast<strong>in</strong>al orhilar lymph node) tuberculosis <strong>in</strong> symptomatic children with negative sputum smears should be based <strong>on</strong><strong>the</strong> f<strong>in</strong>d<strong>in</strong>g <strong>of</strong> chest radiographic abnormalities c<strong>on</strong>sistent with tuberculosis <strong>and</strong> ei<strong>the</strong>r a history <strong>of</strong> exposureto an <strong>in</strong>fectious case or evidence <strong>of</strong> tuberculosis <strong>in</strong>fecti<strong>on</strong> (positive TST or <strong>in</strong>terfer<strong>on</strong> gamma releaseassay). For such patients, if facilities for culture are available, sputum specimens should be obta<strong>in</strong>ed (byexpectorati<strong>on</strong>, gastric wash<strong>in</strong>gs, or <strong>in</strong>duced sputum) for culture.St<strong>and</strong>ard 7. Any practiti<strong>on</strong>er treat<strong>in</strong>g a patient for tuberculosis is assum<strong>in</strong>g an importantpublic health resp<strong>on</strong>sibility. To fulfill this resp<strong>on</strong>sibility <strong>the</strong> practiti<strong>on</strong>er must not <strong>on</strong>ly prescribe anappropriate regimen but, also, be capable <strong>of</strong> assess<strong>in</strong>g <strong>the</strong> adherence <strong>of</strong> <strong>the</strong> patient to <strong>the</strong> regimen <strong>and</strong>address<strong>in</strong>g poor adherence when it occurs. By so do<strong>in</strong>g, <strong>the</strong> provider will be able to ensure adherence to<strong>the</strong> regimen until treatment is completed.St<strong>and</strong>ard 8. All patients (<strong>in</strong>clud<strong>in</strong>g those with HIV <strong>in</strong>fecti<strong>on</strong>) who have not been treatedpreviously should receive an <strong>in</strong>ternati<strong>on</strong>ally accepted first-l<strong>in</strong>e treatment regimen us<strong>in</strong>g drugs <strong>of</strong> knownbioavailability. The <strong>in</strong>itial phase should c<strong>on</strong>sist <strong>of</strong> two m<strong>on</strong>ths <strong>of</strong> is<strong>on</strong>iazid, rifampic<strong>in</strong>, pyraz<strong>in</strong>amide, <strong>and</strong>ethambutol. The preferred c<strong>on</strong>t<strong>in</strong>uati<strong>on</strong> phase c<strong>on</strong>sists <strong>of</strong> is<strong>on</strong>iazid <strong>and</strong> rifampic<strong>in</strong> given for four m<strong>on</strong>ths.Is<strong>on</strong>iazid <strong>and</strong> ethambutol given for six m<strong>on</strong>ths is an alternative c<strong>on</strong>t<strong>in</strong>uati<strong>on</strong> phase regimen that may beused when adherence cannot be assessed, but it is associated with a higher rate <strong>of</strong> failure <strong>and</strong>-168-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!